Tilo Biedermann Selected Research

N,N- dimethylcarbamoyl- 4- (4- guanidinobenzyloxy)phenyl acetate methane sulfate

1/2014

Guideline for acute therapy and management of anaphylaxis: S2 Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Association of German Allergologists (AeDA), the Society of Pediatric Allergy and Environmental Medicine (GPA), the German Academy of Allergology and Environmental Medicine (DAAU), the German Professional Association of Pediatricians (BVKJ), the Austrian Society for Allergology and Immunology (ÖGAI), the Swiss Society for Allergy and Immunology (SGAI), the German Society of Anaesthesiology and Intensive Care Medicine (DGAI), the German Society of Pharmacology (DGP), the German Society for Psychosomatic Medicine (DGPM), the German Working Group of Anaphylaxis Training and Education (AGATE) and the patient organization German Allergy and Asthma Association (DAAB).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tilo Biedermann Research Topics

Disease

36	Hypersensitivity (Allergy) 10/2022 - 11/2005
22	Anaphylaxis (Anaphylactic Shock) 01/2022 - 12/2004
19	Inflammation (Inflammations) 11/2022 - 11/2002
15	Atopic Dermatitis (Atopic Eczema) 07/2022 - 11/2002
10	Psoriasis (Pustulosis Palmaris et Plantaris) 11/2021 - 01/2003
9	red meat allergy 01/2022 - 01/2016
8	Infections 01/2022 - 01/2006
8	Asthma (Bronchial Asthma) 12/2021 - 05/2004
8	Neoplasms (Cancer) 10/2019 - 09/2010
7	Melanoma (Melanoma, Malignant) 12/2021 - 09/2010
7	Dermatitis 09/2020 - 11/2005
6	Skin Diseases (Skin Disease) 01/2022 - 11/2002
6	Bites and Stings (Sting) 01/2020 - 09/2008
5	COVID-19 10/2022 - 01/2020
5	Autoimmune Diseases (Autoimmune Disease) 01/2019 - 01/2003
4	Exercise-Induced Allergies 01/2022 - 01/2019
4	Contact Dermatitis (Eczema, Contact) 01/2018 - 04/2012
3	Seasonal Allergic Rhinitis (Hay Fever) 12/2021 - 01/2020
3	Necrosis 01/2010 - 04/2008
2	Virus Diseases (Viral Diseases) 01/2022 - 01/2008
2	Neoplasm Metastasis (Metastasis) 12/2021 - 09/2010
2	Pruritus (Itching) 12/2021 - 07/2011
2	Mumps 01/2021 - 06/2019
2	Ulcerative Colitis 01/2021 - 09/2020
2	Rubella (German Measles) 01/2021 - 06/2019
2	Measles 01/2021 - 06/2019
2	Carcinoma (Carcinomatosis) 06/2020 - 10/2017
2	Urticaria (Hives) 01/2020 - 07/2011
2	Tick Bites 01/2020 - 01/2019
2	Wounds and Injuries (Trauma) 10/2019 - 01/2014
2	Hepatocellular Carcinoma (Hepatoma) 10/2019 - 01/2016
2	Warts (Wart) 06/2019 - 03/2019
2	Food Hypersensitivity (Food Allergy) 01/2019 - 01/2016
2	Acrodermatitis (Gianotti Crosti Syndrome) 07/2018 - 07/2018
2	Venom Hypersensitivity 01/2018 - 10/2017
2	Eczema 01/2018 - 10/2016
2	Carcinogenesis 11/2017 - 10/2017
2	Allergic Contact Dermatitis 01/2017 - 05/2010
2	Bacterial Infections (Bacterial Infection) 08/2009 - 09/2006
1	Disease Progression 11/2022
1	Scabies (Sarcoptic Mange) 08/2022

Drug/Important Bio-Agent (IBA)

17	AllergensIBA 01/2022 - 11/2002
14	Immunoglobulin E (IgE)IBA 01/2022 - 06/2008
10	CytokinesIBA 01/2022 - 01/2003
9	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2006
7	CarbohydratesIBA 01/2022 - 01/2019
6	Biomarkers (Surrogate Marker)IBA 11/2022 - 01/2019
5	VaccinesIBA 10/2022 - 08/2012
5	EpitopesIBA 01/2022 - 01/2019
5	AntibodiesIBA 09/2020 - 07/2011
4	Biological ProductsIBA 09/2021 - 10/2015
4	Toll-Like Receptors (Toll-Like Receptor)IBA 10/2019 - 01/2006
4	Interleukin-4 (Interleukin 4)IBA 02/2015 - 01/2003
3	TabletsIBA 12/2021 - 01/2019
3	Arthropod VenomsIBA 10/2021 - 01/2018
3	Interleukin-17 (Interleukin 17)IBA 12/2018 - 10/2011
3	Bee Venoms (Bee Venom)IBA 10/2017 - 12/2012
3	LigandsIBA 03/2016 - 03/2012
3	Interleukin-12 (IL 12)IBA 02/2015 - 09/2006
3	Interleukin-10 (Interleukin 10)IBA 07/2014 - 01/2009
3	Peptides (Polypeptides)IBA 01/2014 - 01/2006
3	Wasp Venoms (Venom, Wasp)IBA 08/2013 - 09/2008
2	COVID-19 VaccinesIBA 10/2022 - 01/2022
2	baricitinibIBA 07/2022 - 03/2022
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 10/2016
2	Glutens (Glutelin)IBA 01/2022 - 08/2021
2	GliadinIBA 08/2021 - 01/2019
2	Measles-Mumps-Rubella Vaccine (MMR Vaccine)IBA 01/2021 - 06/2019
2	4'-N,N-dimethylamino-4-aminoazobenzeneIBA 01/2021 - 01/2014
2	dupilumabIBA 01/2021 - 11/2019
2	GelatinIBA 01/2021 - 05/2013
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 01/2009
2	VemurafenibIBA 10/2020 - 01/2013
2	Imiquimod (Aldara)FDA LinkGeneric 09/2020 - 01/2018
2	OligosaccharidesIBA 01/2020 - 01/2020
2	Galactose (Galactopyranose)FDA LinkGeneric 01/2020 - 01/2019
2	VenomsIBA 01/2020 - 08/2018
2	AntigensIBA 01/2020 - 01/2016
2	ORALIT (ORS)IBA 01/2019 - 04/2008
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2019 - 03/2011
2	secukinumabIBA 12/2018 - 04/2016
2	ixekizumabIBA 07/2018 - 07/2018
2	HaptensIBA 01/2018 - 04/2012
2	Toll-Like Receptor 7IBA 01/2018 - 10/2017
2	Ustekinumab (CNTO 1275)FDA Link 01/2018 - 10/2011
2	InterleukinsIBA 11/2017 - 10/2011
2	CeramidesIBA 11/2017 - 01/2014
2	Toll-Like Receptor 2IBA 01/2016 - 07/2014
2	Interleukin-23 (Interleukin 23)IBA 02/2015 - 10/2011
2	Bevacizumab (Avastin)FDA Link 01/2015 - 01/2010
2	Interleukin-6 (Interleukin 6)IBA 11/2014 - 12/2011
2	AutoantibodiesIBA 07/2011 - 06/2007

Therapy/Procedure

29	Therapeutics 11/2022 - 01/2003
8	Immunotherapy 12/2021 - 12/2012
4	Precision Medicine 11/2022 - 10/2016
2	Drug Therapy (Chemotherapy) 12/2021 - 01/2016
2	Critical Care (Surgical Intensive Care) 01/2021 - 01/2014
2	Secondary Prevention 06/2020 - 05/2020
2	Radiotherapy 10/2019 - 10/2018
1	Traditional Medicine (Folk Remedies) 08/2022